CN104718453B - 酸性条件下分析物测定用方法和试剂盒 - Google Patents

酸性条件下分析物测定用方法和试剂盒 Download PDF

Info

Publication number
CN104718453B
CN104718453B CN201380051645.1A CN201380051645A CN104718453B CN 104718453 B CN104718453 B CN 104718453B CN 201380051645 A CN201380051645 A CN 201380051645A CN 104718453 B CN104718453 B CN 104718453B
Authority
CN
China
Prior art keywords
analyte
protein
acid
sample
complex
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201380051645.1A
Other languages
English (en)
Chinese (zh)
Other versions
CN104718453A (zh
Inventor
M·因加纳斯
P·莱赫托宁
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gyros Patent AB
Original Assignee
Gyros Patent AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gyros Patent AB filed Critical Gyros Patent AB
Publication of CN104718453A publication Critical patent/CN104718453A/zh
Application granted granted Critical
Publication of CN104718453B publication Critical patent/CN104718453B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54393—Improving reaction conditions or stability, e.g. by coating or irradiation of surface, by reduction of non-specific binding, by promotion of specific binding
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5306—Improving reaction conditions, e.g. reduction of non-specific binding, promotion of specific binding
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/537—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody
    • G01N33/5375—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody by changing the physical or chemical properties of the medium or immunochemicals, e.g. temperature, density, pH, partitioning
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
CN201380051645.1A 2012-10-03 2013-10-03 酸性条件下分析物测定用方法和试剂盒 Active CN104718453B (zh)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
SE1251116 2012-10-03
SE1251116-8 2012-10-03
SE1350373 2013-03-25
SE1350373-5 2013-03-25
PCT/SE2013/051161 WO2014055025A1 (en) 2012-10-03 2013-10-03 Method and kit for analyte determination at acidic conditions

Publications (2)

Publication Number Publication Date
CN104718453A CN104718453A (zh) 2015-06-17
CN104718453B true CN104718453B (zh) 2017-03-08

Family

ID=50435248

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201380051645.1A Active CN104718453B (zh) 2012-10-03 2013-10-03 酸性条件下分析物测定用方法和试剂盒

Country Status (5)

Country Link
US (1) US10036745B2 (https=)
EP (1) EP2904393B1 (https=)
JP (1) JP6279590B2 (https=)
CN (1) CN104718453B (https=)
WO (1) WO2014055025A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3929584B1 (en) * 2016-09-06 2024-08-14 Fujirebio Inc. Method for measuring thyroglobulin
EP3511713B1 (en) * 2016-09-06 2021-10-27 Fujirebio Inc. Tumor marker measurement method and measurement reagent
TW201812300A (zh) * 2016-09-13 2018-04-01 日商富士麗比歐股份有限公司 心肌肌鈣蛋白之測定方法及測定試藥
MX2020004921A (es) 2017-11-29 2020-08-27 Hoffmann La Roche Ensayo de anticuerpo antifarmaco con supresion de interferencia del objetivo.
KR102718808B1 (ko) 2018-08-03 2024-10-16 브리스톨-마이어스 스큅 컴퍼니 항-약물 항체를 검출하는 방법
CN113960318A (zh) * 2021-09-28 2022-01-21 苏州赛分科技股份有限公司 一种基于酶联免疫的重组蛋白a测定方法及试剂盒
JP2025523802A (ja) * 2022-07-13 2025-07-25 リジェネロン・ファーマシューティカルズ・インコーポレイテッド 分析物を検出するための弱酸性免疫アッセイ

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0213093A1 (en) * 1985-06-03 1987-03-04 Pharmacia Ab Immunoassay method for the determination of Fc-part binding bacterial polypeptides and/or corresponding antibodies
WO1991010911A1 (en) * 1990-01-19 1991-07-25 Repligen Corporation Immunoassay of protein a under acidic conditions
CN101097217A (zh) * 2006-06-29 2008-01-02 王珊珊 一种提高血清特异性生长因子免疫学测定灵敏度的技术
WO2009022001A1 (en) * 2007-08-16 2009-02-19 Novartis Ag Improvement of drug tolerance in immunogenicity testing
CN101583872A (zh) * 2006-09-14 2009-11-18 通用电气健康护理生物科学股份公司 测定待分析物浓度的方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4703001A (en) 1985-10-23 1987-10-27 Synbiotics, Corporation Immunoassay for the detection of serum analytes using pH dependent chastropic acids
US5314804A (en) * 1992-03-24 1994-05-24 Serim Research Corporation Test for Helicobacter pylori
GB9809943D0 (en) 1998-05-08 1998-07-08 Amersham Pharm Biotech Ab Microfluidic device
WO2002074438A2 (en) 2001-03-19 2002-09-26 Gyros Ab Structural units that define fluidic functions
US7759067B2 (en) 2001-03-19 2010-07-20 Gyros Patent Ab Method for determining the amount of an analyte with a disc-shaped microfluidic device
WO2003018198A1 (en) 2001-08-28 2003-03-06 Gyros Ab Retaining microfluidic microcavity and other microfluidic structures
US20040009178A1 (en) * 2002-02-11 2004-01-15 Bowdish Katherine S. Immunotherapeutics for biodefense
SE0200943D0 (sv) 2002-03-25 2002-03-25 Amersham Biosciences Ab Mutant protein
JP4115728B2 (ja) 2002-03-26 2008-07-09 デンカ生研株式会社 フロースルー式検査法用組成物、これを用いたキット及び検査法
EP1509760A1 (en) * 2002-05-31 2005-03-02 Gyros AB Detector arrangement based on surface plasmon resonance
SE0300822D0 (sv) 2003-03-23 2003-03-23 Gyros Ab A collection of Micro Scale Devices
JP5171034B2 (ja) 2003-03-23 2013-03-27 ユィロス・パテント・アクチボラグ 充填済みのマイクロスケール装置
WO2008033073A1 (en) * 2006-09-14 2008-03-20 Ge Healthcare Bio-Sciences Ab A method of determining analyte concentration
US20080125454A1 (en) * 2006-10-05 2008-05-29 Wyeth Methods and Compositions for Treatment of Scleritis and Related Disorders
US20110045510A1 (en) * 2008-04-03 2011-02-24 Kurt Lang Pegylated insulin-like-growth-factor assay
PT2329266E (pt) 2008-09-11 2016-06-07 Pasteur Institut Monitorização e inibição da infecção pelo vírus da imunodeficiência humana mediante modulação do desencadeamento dependente de hmgb1 da replicação e persistência do vih-1
US8546149B2 (en) * 2010-08-27 2013-10-01 Intervet Inc. Potency test for vaccine formulations
CA2827609A1 (en) * 2011-02-17 2012-11-15 Nestec S.A. Assays for detecting autoantibodies to anti-tnf.alpha. drugs
AU2013219968B2 (en) * 2012-02-15 2018-11-08 Biocon Limited A process for detection and optional quantification of an analyte

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0213093A1 (en) * 1985-06-03 1987-03-04 Pharmacia Ab Immunoassay method for the determination of Fc-part binding bacterial polypeptides and/or corresponding antibodies
WO1991010911A1 (en) * 1990-01-19 1991-07-25 Repligen Corporation Immunoassay of protein a under acidic conditions
CN101097217A (zh) * 2006-06-29 2008-01-02 王珊珊 一种提高血清特异性生长因子免疫学测定灵敏度的技术
CN101583872A (zh) * 2006-09-14 2009-11-18 通用电气健康护理生物科学股份公司 测定待分析物浓度的方法
WO2009022001A1 (en) * 2007-08-16 2009-02-19 Novartis Ag Improvement of drug tolerance in immunogenicity testing

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
An acid dissociation bridging ELISA for detection of antibodies directed against therapeutic proteins in the presence of antigen;Aaron Patton 等;《Journal of Immunological Methods 》;20050725;第304卷;189-195 *
An Affinity Capture Elution (ACE) assay for detection of anti-drug antibody to monoclonal antibody therapeutics in the presence of high levels of drug;James S. Bourdage 等;《Journal of Immunological Methods》;20070727;第327卷;10-17 *
Detection of antibodies against therapeutic proteins in the presence of residual therapeutic protein using a solid-phase extraction with acid dissociation (SPEAD) sample treatment prior to ELISA;Holly W. Smith 等;《Regulatory Toxicology and Pharmacology》;20070807;第49卷;230-237 *
Improvement of drug tolerance in immunogenicity testing by acid treatment on Biacore;Denise Sickert 等;《Journal of Immunological Methods》;20080214;第334卷;29-36 *

Also Published As

Publication number Publication date
JP6279590B2 (ja) 2018-02-14
EP2904393A1 (en) 2015-08-12
US20150268238A1 (en) 2015-09-24
CN104718453A (zh) 2015-06-17
EP2904393B1 (en) 2018-11-28
EP2904393A4 (en) 2016-05-04
US10036745B2 (en) 2018-07-31
JP2015531487A (ja) 2015-11-02
WO2014055025A1 (en) 2014-04-10

Similar Documents

Publication Publication Date Title
CN104718453B (zh) 酸性条件下分析物测定用方法和试剂盒
Zhang et al. High performance affinity chromatography and related separation methods for the analysis of biological and pharmaceutical agents
KR101826449B1 (ko) 펩티드 단편의 조제 방법 및 그것에 사용되는 펩티드 단편 조제용 킷, 및 분석 방법
US10648988B2 (en) Methods for providing information relevant to diagnosis of neurodegenerative disorder
Miyazaki et al. Evidence for the presence of lipid-free monomolecular apolipoprotein A-1 in plasma
Morgan Measurement of complement hemolytic activity, generation of complement-depleted sera, and production of hemolytic intermediates
JP7382071B2 (ja) 糖化ヘモグロビン（％）の測定方法
JP2023533806A (ja) タウオパチー又はアミロイド形成疾患を検出するための血液ベースのアッセイ
Lekchnov et al. Human placenta: Relative content of antibodies of different classes and subclasses (IgG1–IgG4) containing lambda-and kappa-light chains and chimeric lambda-kappa-immunoglobulins
US20050095726A1 (en) Novel high protein tortillas
Sharmeen et al. Immunoaffinity chromatography for protein purification and analysis
JPH07238096A (ja) 抗ポリユビキチン・モノクローナル抗体およびポリユビキチンの測定方法
Hnasko The biochemical properties of antibodies and their fragments
Kent Purification of antibodies using protein A-sepharose and FPLC
Zhu-Shimoni et al. Trace level analysis of leached Protein A in bioprocess samples without interference from the large excess of rhMAb IgG
Ayouba et al. Quantitative analysis of multiple V‐region interactions among normal human IgG
US20210055300A1 (en) Monoclonal antibody against apoa4, immunological measurement method, and kit for measurement
JP5448424B2 (ja) ヒトＩｇＧのＦｃを含有するタンパク質の測定試薬
US9151747B1 (en) Sucralose antibody and immunoassay
JP5231954B2 (ja) アルブミン測定試薬
Cho et al. Minimum-step immuno-analysis based on continuous recycling of the capture antibody
Tillib et al. Development of an anchor bispecific nanoantibody to improve the efficiency of antigen immobilization and detection in a well of a polystyrene plate
Mortezai et al. Combining lectin affinity chromatography and immunodepletion–A novel method for the enrichment of disease-specific glycoproteins in human plasma
US20180246121A1 (en) Immunological test method and immunological test kit
US20060275849A1 (en) Monoclonal antibody reagents

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant